@FierceMedDev: Startup brings molecular diagnostics to India's swelling market. Article | Follow @FierceMedDev
@MarkHFierce: Today's Dx Extra: Another company will take on development of an RA Dx. Story | Follow @MarkHFierce
@DamianFierce: After a weak Q4, Zimmer's counting on restructuring to save 2013 profits. News | Follow @DamianFierce
> Thermo Fisher ($TMO) posted a record $3.26 billion in fourth-quarter revenue, a 6% jump over the same period in 2011. Results
> Vycor Medical has launched a Class I recall of some of its Viewsite brain access devices, warning of serious adverse events including death. More
> California's Velomedix has enrolled the first patient in a trial of its device that works to cool the peritoneal cavity during myocardial infarction procedures. Release
> As more and more cancer drugs come paired with companion diagnostics, Dx companies are cashing in and advancing the field. Article
> Arteriocyte got the FDA's sign-off to launch a trial of its Magellan device to treat thermal burn wounds. Item
Biotech News
@FierceBiotech: Celsion shares routed after PhIII liver cancer study flops. News | Follow @FierceBiotech
@JohnCFierce: AstraZeneca's Soriot is going to have to do something bold, something dramatic, and something a little loony. In that order. | Follow @JohnCFierce
@RyanMFierce: Holland's health minister is sounding very German on drug pricing, wants to chop cost of Genzyme and Shire therapies. More | Follow @RyanMFierce
> Venture firm preps $100M fund for late-stage life sciences investments. News
> Vanda slides after drug fails PhII/III for depression. Item
> Is AstraZeneca getting ready to buy a pipeline? Report
> Pharmaxis suffers FDA committee upset, nabs up to $40M in financing. Article
> Genentech flashes PhIII progress for prized Rituxan successor. Story
Pharma News
@FiercePharma: EMA sounds a bit perturbed about France's suspension of Diane-35. But it will review data when France asks. More | Follow @FiercePharma
@AlisonBFierce: Life Technologies established an international flu network to develop a speedy monitoring system and better vaccine. News | Follow @AlisonBFierce
@EricPFierce: BASF says it has finally gotten the Pronova deal closed making it one of the largest fish oil producers in the world. Release | Follow @EricPFierce
> Novo meets 'sky-high' expectations with 18% sales growth. Report
> Genzyme's $176K Kynamro price undercuts its $250K-plus rival. Article
> Patent Cliff II: Nightmare on blockbuster street returns in 2015. News
Vaccines News
> MIT explores DNA vaccine delivery. Item
> Life establishes international flu network. More
> CDC: Adult vaccination rates 'unacceptably low.' Report
> FDA expands use of Pfizer's Prevnar 13. Article
> GSK, Biological E partner on childhood vaccine. Story
Pharma Manufacturing News
> Cargo theft up dramatically in Mexico. Item
> Sanofi's Genzyme looking hard at continuous manufacturing. News
> Biogen, Merck, Novartis, others have plants recognized for innovations. More
> Teva, P&G start on OTC plant in India. Story